Insight Molecular Diagnostics

IMDX · NASDAQ

$3.03+$0.14 (+4.84%)TodayMarket closed ·
Prev close $2.89

Who owns IMDX

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 75.0% of IMDX’s shares.

  • Broadwood Capital, Inc.39.3%
  • Smith (Patrick W)10.1%
  • Bio-Rad Laboratories, Inc.9.9%
  • AWM Investment Company, Inc.8.8%
  • Next 6 largest institutions6.9%
  • All other shareholders25.0%
Top institutional holders of IMDX
HolderShares% of shares
Broadwood Capital, Inc.12.68M39.28%
Smith (Patrick W)3.26M10.09%
Bio-Rad Laboratories, Inc.3.20M9.92%
AWM Investment Company, Inc.2.84M8.79%
Vanguard Capital Management, LLC735.85K2.28%
Pura Vida Investments, LLC484.85K1.50%
Family Office Research LLC368.85K1.14%
Geode Capital Management, L.L.C.256.90K0.80%
James (Andrea S.)206.06K0.64%
FNY Investment Advisers LLC182.56K0.57%

Largest mutual fund holders

Top mutual fund holders of IMDX
HolderShares% of shares
Vanguard Total Stock Market Index Fund475.40K1.47%
Vanguard Extended Market Index Fund248.06K0.77%
Fidelity Extended Market Index Fund108.02K0.33%
iShares Micro-Cap ETF43.83K0.14%
Fidelity Total Market Index Fund38.62K0.12%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders bought $2.03M (3 trades) of IMDX on the open market, with no sales.

Latest IMDX insider transactions
InsiderTypeSharesValue
Last Andrew J.Tax withholding7.70K$43.81K
Arno AndrewTax withholding12.10K$68.85K
SILVERMAN LOUTax withholding7.70K$43.81K
Last Andrew J.Award26.94K—
Arno AndrewAward32.33K—
SILVERMAN LOUAward26.94K—
BROADWOOD PARTNERS, L.P.Buy250.92K$913.13K
BROADWOOD PARTNERS, L.P.Buy38.88K$137.08K
BROADWOOD PARTNERS, L.P.Buy280.38K$982.03K

Short interest

Settled Sep 30, 2026

Shares short
973.03K
Days to cover
2.91
% of shares outstanding
3.01%
Average daily volume
334.26K
Change since last report
−2.0%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.